ResMed | RMD - 应收帐款人

金融业

USD

USD 8.97B

现金及等价物

USD 1.47B

USD 612.93M

USD 4.32B

USD 1.4B

USD 843.17M

股息收益率

0.28

USD 454.34M

USD 559.78M

10.6K

EPS每股收益

USD 2.95

股本和储备

USD 6.59B

USD 861.22M

债务利息支出

USD 8.79M

USD 59K

USD 399.42M

USD 32.61B

USD 383.43M

USD 1.01B

USD 454.34M

普通股股本

USD 145.06M

18.29

USD 502.31M

USD 1.46B

销售和管理费用

USD 290.66M

USD 945.81M

贸易债权人

USD 308.92M

应收帐款人

USD 1.04B

	应收帐款人	更改		日
Ansell	USD 231.1M		15.4M	2025-12
Artivion	USD 103.68M		6.31M	2025-12
AtriCure	USD 79.98M		8.67M	2026-06
Baxter International	USD 1.86B		158M	2026-06
Cochlear	AUD 568.4M		17.5M	2025-12
Cooper Companies	USD 809.2M		2.1M	2026-03
CSL	USD 4.32B		1.35B	2025-12
Dexcom	USD 1.27B		175.4M	2026-06
Edwards Lifesciences	USD 973M		60.9M	2026-03
Fisher Paykel Healthcare	NZD 347.5M		11.8M	2026-06
Globus Medical	USD 739.28M		3.84M	2026-06
Haemonetics	USD 216.07M		784K	2026-06
Idexx Laboratories	USD 627.08M		70.13M	2026-06
Inogen	USD 37.09M		4.11M	2024-06
Insulet	USD 588.7M		44M	2026-06
Integra LifeSciences	USD 267.19M		2.78M	2026-06
Intuitive Surgical	USD 1.67B		77.6M	2026-06
Medtronic	USD 6.36B		30M	2025-12
Philips	EUR 3.6B		70M	2026-06
Ramsay Health Care	AUD 2.48B		22.3M	2025-12
ResMed	USD 1.04B		37.4M	2026-06
Sigma Healthcare	AUD 2.56B		2.23B	2025-12
Sonic Healthcare	AUD 1.39B		23.76M	2024-12
Steris	USD 1.01B		79.6M	2026-06
Teleflex	USD 364.61M		917K	2026-06
Thermo Fisher Scientific	USD 9.45B		247M	2026-06